May 18, 2023 02:05 PM EDT

CDER leaders ready to implement swifter accelerated approval withdrawal process

Zachary Brennan

Senior Editor

With the long Makena accelerated approval withdrawal saga fresh in their minds, both the director of the FDA’s Center for Drug Evaluation and Research …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

CDER leaders ready to implement swifter accelerated approval withdrawal process

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

CDER lead­ers ready to im­ple­ment swifter ac­cel­er­at­ed ap­proval with­draw­al process

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

CDER leaders ready to implement swifter accelerated approval withdrawal process